These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 15814242)

  • 1. A critical evaluation of the relevant parameters for drug redispersion from adhesive mixtures during inhalation.
    de Boer AH; Dickhoff BH; Hagedoorn P; Gjaltema D; Goede J; Lambregts D; Frijlink HW
    Int J Pharm; 2005 Apr; 294(1-2):173-84. PubMed ID: 15814242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction between carrier rugosity and carrier payload, and its effect on drug particle redispersion from adhesive mixtures during inhalation.
    Dickhoff BH; de Boer AH; Lambregts D; Frijlink HW
    Eur J Pharm Biopharm; 2005 Jan; 59(1):197-205. PubMed ID: 15567318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of carrier surface treatment on drug particle detachment from crystalline carriers in adhesive mixtures for inhalation.
    Dickhoff BH; de Boer AH; Lambregts D; Frijlink HW
    Int J Pharm; 2006 Dec; 327(1-2):17-25. PubMed ID: 16920287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of carrier surface and bulk properties on drug particle detachment from crystalline lactose carrier particles during inhalation, as function of carrier payload and mixing time.
    Dickhoff BH; de Boer AH; Lambregts D; Frijlink HW
    Eur J Pharm Biopharm; 2003 Sep; 56(2):291-302. PubMed ID: 12957644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical view on lactose-based drug formulation and device studies for dry powder inhalation: which are relevant and what interactions to expect?
    de Boer AH; Chan HK; Price R
    Adv Drug Deliv Rev; 2012 Mar; 64(3):257-74. PubMed ID: 21565232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Air classifier technology (ACT) in dry powder inhalation. Part 2. The effect of lactose carrier surface properties on the drug-to-carrier interaction in adhesive mixtures for inhalation.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Kussendrager KD; Frijlink HW
    Int J Pharm; 2003 Jul; 260(2):201-16. PubMed ID: 12842340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mode of drug particle detachment from carrier crystals in an air classifier-based inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Lambregts D; Irngartinger M; Frijlink HW
    Pharm Res; 2004 Dec; 21(12):2167-74. PubMed ID: 15648247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Air classifier technology (ACT) in dry powder inhalation. Part 1. Introduction of a novel force distribution concept (FDC) explaining the performance of a basic air classifier on adhesive mixtures.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
    Int J Pharm; 2003 Jul; 260(2):187-200. PubMed ID: 12842339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rate of drug particle detachment from carrier crystals in an air classifier-based inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Lambregts D; Irngartinger M; Frijlink HW
    Pharm Res; 2004 Dec; 21(12):2158-66. PubMed ID: 15648246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM; MacRitchie HB; Marriott C; Martin GP
    Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A proposed definition of the 'activity' of surface sites on lactose carriers for dry powder inhalation.
    Grasmeijer F; Frijlink HW; de Boer AH
    Eur J Pharm Sci; 2014 Jun; 56():102-4. PubMed ID: 24613490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Air classifier technology (ACT) in dry powder inhalation Part 3. Design and development of an air classifier family for the Novolizer multi-dose dry powder inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):72-80. PubMed ID: 16442248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the effect of lactose particle size on the properties of DPI formulations using experimental design.
    Guenette E; Barrett A; Kraus D; Brody R; Harding L; Magee G
    Int J Pharm; 2009 Oct; 380(1-2):80-8. PubMed ID: 19596428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrostatic characterisation of inhaled powders: effect of contact surface and relative humidity.
    Elajnaf A; Carter P; Rowley G
    Eur J Pharm Sci; 2006 Dec; 29(5):375-84. PubMed ID: 16952450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the effects of blending, physicochemical properties, and their interactions on the performance of carrier-based dry powders for inhalation - A review.
    Kaialy W
    Adv Colloid Interface Sci; 2016 Sep; 235():70-89. PubMed ID: 27291646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adhesion and redistribution of salmeterol xinafoate particles in sugar-based mixtures for inhalation.
    Adi H; Larson I; Stewart PJ
    Int J Pharm; 2007 Jun; 337(1-2):229-38. PubMed ID: 17303354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug/lactose co-micronization by jet milling to improve aerosolization properties of a powder for inhalation.
    Giry K; Péan JM; Giraud L; Marsas S; Rolland H; Wüthrich P
    Int J Pharm; 2006 Sep; 321(1-2):162-6. PubMed ID: 16797150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adhesion forces in interactive mixtures for dry powder inhalers--evaluation of a new measuring method.
    Lohrmann M; Kappl M; Butt HJ; Urbanetz NA; Lippold BC
    Eur J Pharm Biopharm; 2007 Sep; 67(2):579-86. PubMed ID: 17418548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterisation of interactive mixtures with a fine-particulate mucoadhesive carrier for nasal drug delivery.
    Fransén N; Björk E; Nyström C
    Eur J Pharm Biopharm; 2007 Sep; 67(2):370-6. PubMed ID: 17451925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.